AU2003234650A1 - 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents - Google Patents

3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents Download PDF

Info

Publication number
AU2003234650A1
AU2003234650A1 AU2003234650A AU2003234650A AU2003234650A1 AU 2003234650 A1 AU2003234650 A1 AU 2003234650A1 AU 2003234650 A AU2003234650 A AU 2003234650A AU 2003234650 A AU2003234650 A AU 2003234650A AU 2003234650 A1 AU2003234650 A1 AU 2003234650A1
Authority
AU
Australia
Prior art keywords
mmol
compound
stirred
methanol
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003234650A
Other languages
English (en)
Inventor
Todd C. Henninger
Mark J. Macielag
Brett A. Marinelli
Bin Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU2003234650A1 publication Critical patent/AU2003234650A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2003234650A 2002-05-31 2003-05-28 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents Abandoned AU2003234650A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38448302P 2002-05-31 2002-05-31
US60/384,483 2002-05-31
PCT/US2003/016617 WO2003102010A1 (en) 2002-05-31 2003-05-28 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents

Publications (1)

Publication Number Publication Date
AU2003234650A1 true AU2003234650A1 (en) 2003-12-19

Family

ID=29712041

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003234650A Abandoned AU2003234650A1 (en) 2002-05-31 2003-05-28 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents

Country Status (7)

Country Link
US (1) US6825172B2 (cg-RX-API-DMAC10.html)
EP (1) EP1513856A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005531603A (cg-RX-API-DMAC10.html)
CN (1) CN1671726A (cg-RX-API-DMAC10.html)
AU (1) AU2003234650A1 (cg-RX-API-DMAC10.html)
CA (1) CA2487918A1 (cg-RX-API-DMAC10.html)
WO (1) WO2003102010A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100695322B1 (ko) 2005-02-23 2007-03-15 (주)에스.앤.디 메밀등겨로부터 수용성섬유소 및 파고피리톨의 저온 및 연속추출 방법
EP1954294A2 (en) * 2005-11-23 2008-08-13 Ranbaxy Laboratories Limited Use of macrolide derivatives for treating acne
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
EP2871188B1 (en) * 2012-07-06 2017-04-19 Godo Shusei Co., Ltd. Method for separating cyclic macrolide compound

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
IL99995A (en) 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
PT876388E (pt) * 1995-11-08 2004-07-30 Abbott Lab Derivados de eritromicina triciclica
DE69733439T2 (de) * 1996-09-04 2006-05-04 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US6191118B1 (en) 1996-11-27 2001-02-20 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
US6037137A (en) * 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
WO1999021869A1 (en) 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
JP2004514643A (ja) * 1997-10-29 2004-05-20 大正製薬株式会社 エリスロマイシンa誘導体
WO1999021868A1 (fr) 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
US6020521A (en) 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
AU775637B2 (en) 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
GB9910079D0 (en) 1999-05-01 1999-06-30 Smithkline Beecham Plc Novel compounds
ATE250076T1 (de) * 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
WO2001010878A1 (fr) 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6183800A (en) 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6498146B1 (en) * 1999-10-28 2002-12-24 Pfizer Inc Erythromycin derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CA2469304A1 (en) * 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials

Also Published As

Publication number Publication date
WO2003102010A1 (en) 2003-12-11
JP2005531603A (ja) 2005-10-20
CA2487918A1 (en) 2003-12-11
US20040018994A1 (en) 2004-01-29
EP1513856A1 (en) 2005-03-16
CN1671726A (zh) 2005-09-21
US6825172B2 (en) 2004-11-30

Similar Documents

Publication Publication Date Title
US6472372B1 (en) 6-O-Carbamoyl ketolide antibacterials
US6124269A (en) 2-Halo-6-O-substituted ketolide derivatives
US6054435A (en) 6-O-substituted macrolides having antibacterial activity
US6046171A (en) 6,11-bridged erythromycin derivatives
AP1189A (en) C-4"-substituted macrolide derivatives.
AP1060A (en) Novel erythromycin derivatives.
EP0895999A1 (en) C-4" substituted macrolide antibiotics
US5780605A (en) 6,9-bridged erythromycin derivatives
AU751448B2 (en) 2-halo-6-O-substituted ketolide derivatives
WO1997019095A1 (en) 6-0-methyl erythromycin d and process for making
EP0922050A1 (en) 3-descladinose-2,3-anhydroerythromycin derivatives
US6825170B2 (en) 6-O-acyl ketolide antibacterials
US6713455B2 (en) 6-O-carbamate-11,12-lacto-ketolide antimicrobials
US6825172B2 (en) 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
EP0262904A2 (en) Modifications of mycinose and 3-0-demethylmycinose in tylosintype macrolides
US20050250713A1 (en) 11,12-Cyclic thiocarbamate macrolide antibacterial agents
JP2005538927A (ja) アミドマクロライド
WO2006047167A2 (en) 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application